Newsfeeds - Spark Newswire

1 minute read

Viveve Medical Q2 EPS $(0.49) Beats $(0.65) Estimate, Sales $1.70M Beat $1.52M Estimate

Today, 12:08 PM

Viveve Medical (NASDAQ:VIVE) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.65) by 24.62 percent. This is a 8.89 percent decrease over losses of $(0.45) per share from the

VIVE

5 minute read

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma

By Shanthi Rexaline

Today, 12:08 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11)

ABCL

15 minute read

Earnings Scheduled For August 12, 2021

By Benzinga Insights

Today, 12:08 PM

Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.

AACG

2 minute read

Earnings

Preview: Viveve Medical’s Earnings

By Benzinga Insights

Today, 12:08 PM

On Thursday, August 12, Viveve Medical (NASDAQ:VIVE) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.

VIVE

5 minute read

The Daily Biotech Pulse: FDA Rejects FibroGen’s Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering

By Shanthi Rexaline

Today, 12:08 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10)

ACAD

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 12:08 PM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL

1 minute read

Legal
News

Viveve Says Issued Canadian Patent For Co’s Dual-Energy Technology Device And Method

By Benzinga Newsdesk

Today, 12:08 PM

Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the Canadian Intellectual Property Office (CIPO) recently issued Canadian Patent No. 3028905

VIVE

2 minute read

Viveve Announces AMA Has Issued New Category III CPT Code For Its Stress Urinary Incontinence Procedure

By Bill Haddad

Today, 12:08 PM

Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the American Medical Association (AMA) has issued a new Category III Current Procedural

VIVE

1 minute read

Events
News

Viveve Medical Shares Up ~1%; Co Set To Hold Previously Adjourned Annual Meeting At 12 p.m. Today

By Benzinga Newsdesk

Today, 12:08 PM

Vote by Internet at www.proxyvote.com until 11:59 PM Eastern Time on June 22, 2021 using the 16-digit control number appearing on the proxy card. Vote by telephone by calling the toll-free telephone

VIVE

1 minute read

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

Today, 12:08 PM

BSGM